IDEXX chief medical officer announces 2019 retirementOctober 10, 2018IDEXX Laboratories Inc. is in the market for a new chief medical officer after Roberta Relford, DVM, MS, PhD, DACVIM, DAVCP, announced her plans for retirement early next year. Dr. Relford, who joined IDEXX in 1996 and has served as its CMO since 2013, is leaving the company to pursue a new opportunity raising and training colts for working ranches across the U.S. "As many of you know, I have a new partner, and he and I are about to begin a fascinating and exciting new chapter in our life together," she said. "We are embarking on a new journey where we will be training colts and traveling the country. "I didn't make this decision lightly," Relford added. "I leave behind the best job and career a person could ask for. At IDEXX, I have been part of setting new and higher standards of care for pets around the world, and I can't imagine a better team with which to do this important work." Relford received her DVM from Auburn University, a master's degree from Mississippi State University, and a PhD in veterinary pathology from Texas A&M University, where she also pursued advanced training in small animal internal medicine. Check …
SPONSORED CONTENTHow can you help new pet owners keep their new dogs protected?See why new dog owners and their pets can benefit from simple triple protection in one monthly chew. + See the Difference
Zoetis appoints US Diagnostics executive director and chief medical officerJanuary 10, 2018Zoetis has appointed Richard E. Goldstein, DVM, DACVIM, DECVIM-CA to the position of executive director and chief medical officer, US Diagnostics, effective Feb. 5. Dr. Goldstein will lead the diagnostics team in expanding its product portfolio and will spearhead the division's studies and publishing opportunities. "Dr. Goldstein is a well-respected, internationally-renowned veterinarian in small animal internal medicine and we're honored to have him join our Zoetis team," said Lisa Lee, vice president, US Diagnostics and Business Solutions, Zoetis. "His award-winning work, research, and passion for preventing genetic and infectious diseases make him an ideal fit for our company as we continue to develop innovative technologies and solutions to diagnose disease as well as treat and improve the lives of pets." In his role at Zoetis, Goldstein will work closely with the US Companion Animal Division to develop educational events for sales and marketing, while leading the company's "Predict, Prevent, Detect and Treat" strategy. He also will manage the Key Opinion Leader program. Goldstein and his team will continue to emphasize digital innovation, diagnostics, genetic tests, and biodevices as important tools to help veterinarians make better healthcare decisions informed by data. Prior to joining Zoetis, Goldstein spent 12 …
